Pas de connexion internet — affichage de la version enregistrée de la page.

Vaxcyte Inc

USUSD
← Vers le Screener
US:PCVXMI:1PCVX

Vaxcyte Inc (US:PCVX) — Biotechnology: Biological Products (No Diagnostic Substances). Nombre de places boursières sur lesquelles les actions de la société sont cotées : 2. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.

À propos de l'entreprise

Site Web
vaxcyte.com
Relations avec les Investisseurs
investors.vaxcyte.com/
Secteur
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Siège Social
SAN CARLOS, United States
PDG
Grant E. Pickering
Employés
507
Actions en Circulation
148.81 M au 2026-08-03
Flottant
136.44 M
Capitalisation Boursière
8.34 Md USD
Initiés
0.5%
Investisseurs Institutionnels
113.47%
Secteur d'Activité (SIC)
Biological Products, (No Diagnostic Substances)
ISIN
US92243G1085
LEI
254900M7NMHTGASX8D95
P/E
perte
FCF
−894 M USD
Dette
?
Résultats et FCF — pour les 12 mois à 30.06.2026 (dernier rapport de l'entreprise).
NAV
19.05 USD · P/NAV 3.55
Date du Bilan30.06.2026
Actifs3.14 Md USD
− Passifs380 M USD
= NAV (capitaux propres des actionnaires de la société)2.76 Md USD
= NAV Tangible2.76 Md USD
Actions144 785 934
NAV par Action19.05 USD
VLV Tangible par Action19.05 USD
Prix de l'Action (PCVX)67.5500 USD
P/NAV3.55
Historique de la NAV
Date du BilanNAVNAV par Action
30.06.20262.76 Md USD19.05 USD
31.03.20263.00 Md USD20.76 USD
31.12.20252.69 Md USD20.49 USD
30.09.20252.89 Md USD22.25 USD
30.06.20253.07 Md USD23.66 USD
31.03.20253.20 Md USD24.82 USD
31.12.20243.31 Md USD26.47 USD
30.09.20243.42 Md USD27.47 USD
Description

Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; VAX-GI, a novel preclinical vaccine candidate for the treatment of dysentery and shigellosis, which is caused by Shigella bacteria; and VAX-XL, a third-generation pneumococcal conjugate vaccine. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.

publicité

Bourses et Tickers

BourseTickerDevisePrixType
US USA StocksPCVX principaleUSD67.55 +1.12%actions ordinaires
MI Borsa Italiana (Milan)1PCVX secondaireEUR59.5 -2.46%actions ordinaires

Cours sur 3 Mois

jour de hausse jour de baisseSurvolez / touchez un jour — cours d'ouverture, de clôture, plus haut et plus bas

Principaux Actionnaires

DétenteurParticipationActionsDate du Rapport
FMR, LLC14.01%20.85 M2026-06-30
Jupiter Topco LLC12.07%17.97 M2026-06-30
T. Rowe Price Investment…8.2%12.21 M2026-06-30
Blackrock Inc.8.11%12.07 M2026-06-30
RA Capital Management, L…7.71%11.47 M2026-06-30
Wellington Management Gr…4.71%7 M2026-06-30
Vanguard Portfolio Manag…4.43%6.59 M2026-06-30
Vanguard Capital Managem…4.27%6.35 M2026-06-30
State Street Corporation3.6%5.35 M2026-06-30
VANGUARD INDEX FUNDS-Van…3.08%4.59 M2026-06-30
Deep Track Capital, Lp2.89%4.3 M2026-06-30
T. ROWE PRICE CAPITAL AP…2.69%4.01 M2026-06-30
iShares Trust-iShares Ru…2.27%3.37 M2026-08-31
VANGUARD INDEX FUNDS-Van…2.23%3.31 M2026-06-30
Fidelity Rutland Square…2.11%3.14 M2026-07-31
JANUS INVESTMENT FUND-Ja…1.8%2.68 M2026-06-30
VANGUARD SPECIALIZED FUN…1.57%2.34 M2026-07-31
SPDR SERIES TRUST-State…1.55%2.31 M2026-08-31
JANUS INVESTMENT FUND-Ja…1.53%2.27 M2026-06-30
VANGUARD INDEX FUNDS-Van…1.28%1.91 M2026-06-30
GUGGENHIME ANDREW (Presi…≈0.11%167 0262026-08-03
WASSIL JAMES (Chief Oper…≈0.1%145 4352026-09-09
DHALIWAL HARPREET S. (Of…≈0.05%76 7562026-08-05
JODAR LUIS (Officer)≈0.04%52 6322026-09-04
EYDELMAN MIKHAIL (Genera…≈0.03%41 6202025-03-05
COWAN ELVIA (Officer)≈0.02%28 9752026-04-07
LUKATCH HEATH SCOTT (Dir…≈0.01%19 4812026-06-15
LOXAM TERI (Director)≈0.01%12 4812026-06-15
PAYA CARLOS V (Director)≈0.01%12 4812026-06-15
PICKERING GRANT E (Chief…——2026-07-27